(E)-2-Benzylidenecyclanones: Part XIX. Reaction of (E)-2-(4′-X-Benzylidene)-1-tetralones with Cellular Thiols: Comparison of Thiol Reactivities of Open-Chain Chalcones and Their Six- and Seven-Membered Cyclic Analogs
International Journal of Molecular Sciences · 16.07.2024 · 25 (14) · 7773
DOI: 10.3390/ijms25147773 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.07.2024. Verfasst von Fatemeh Kenari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Chemistry, University of Pécs, H-7624 Pécs, Hungary. Hauptthemen laut MEDLINE: Chalcones, Sulfhydryl Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.
Abstract (Originalsprache)
Non-enzyme-catalyzed thiol addition onto the α,β-unsaturated carbonyl system is associated with several biological effects. Kinetics and diastereoselectivity of non-enzyme catalyzed nucleophilic addition of reduced glutathione (GSH) and N-acetylcysteine (NAC) to the six-membered cyclic chalcone analogs 2a and 2b were investigated at different pH values (pH 3.2, 7.4 and 8.0). The selected compounds displayed in vitro cancer cell cytotoxicity (IC50) of different orders of magnitude. The chalcones intrinsically reacted with both thiols under all incubation conditions. The initial rates and compositions of the final mixtures depended both on the substitution and the pH. The stereochemical outcome of the reactions was evaluated using high-pressure liquid chromatography with UV detection (HPLC-UV). The structures of the formed thiol-conjugates and the retro-Michael products (Z)-2a and (Z)-2b were confirmed by high-pressure liquid chromatography-mass spectrometry (HPLC-MS). Frontier molecular orbitals and the Fukui function calculations were carried out to investigate their effects on the six-membered cyclic analogs. Data were compared with those obtained with the open-chain (1) and the seven-membered (3) analogs. The observed reactivities do not directly relate to the difference in in vitro cancer cell cytotoxicity of the compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Chemistry, University of Pécs, H-7624 Pécs, Hungary.
- Research Institute for Viticulture and Oenology, University of Pécs, H-7634 Pécs, Hungary.
- Grupo de Química Teórica e Estrutural de Anápolis, Universidade Estadual de Goiás, Anápolis 75132-903, GO, Brazil.
ORCID-Profile: Fatemeh Kenari, Szilárd Molnár, Ademir J Camargo, Pál Perjési
Förderung
- European Union
Zitieren
APA
Kenari, F., Pintér, Z., Molnár, S., Borges, I. D., Camargo, A. J., Napolitano, H. B., & Perjési, P. (2024). (E)-2-Benzylidenecyclanones: Part XIX. Reaction of (E)-2-(4′-X-Benzylidene)-1-tetralones with Cellular Thiols: Comparison of Thiol Reactivities of Open-Chain Chalcones and Their Six- and Seven-Membered Cyclic Analogs. International Journal of Molecular Sciences, 25(14), 7773. https://doi.org/10.3390/ijms25147773
Vancouver
Kenari F, Pintér Z, Molnár S, Borges ID, Camargo AJ, Napolitano HB, et al. (E)-2-Benzylidenecyclanones: Part XIX. Reaction of (E)-2-(4′-X-Benzylidene)-1-tetralones with Cellular Thiols: Comparison of Thiol Reactivities of Open-Chain Chalcones and Their Six- and Seven-Membered Cyclic Analogs. International Journal of Molecular Sciences. 2024;25(14):7773. doi:10.3390/ijms25147773
BibTeX
@article{Kenari2024,
author = {Kenari, Fatemeh and Pintér, Zoltán and Molnár, Szilárd and Borges, Igor D and Camargo, Ademir J and Napolitano, Hamilton B and Perjési, Pál},
title = {(E)-2-Benzylidenecyclanones: Part XIX. Reaction of (E)-2-(4′-X-Benzylidene)-1-tetralones with Cellular Thiols: Comparison of Thiol Reactivities of Open-Chain Chalcones and Their Six- and Seven-Membered Cyclic Analogs},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {14},
pages = {7773},
doi = {10.3390/ijms25147773}
}
EUVIMED